We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Source of Dangerous Heart Infection Discovered

By Biotechdaily staff writers
Posted on 23 May 2002
Researchers have discovered important clues as to why a common bacterium can sometimes lead to a dangerous heart infection in children. More...
Their findings were reported in the March 26, 2002, issue of the Proceedings of the National Academy of Sciences.

The bacterium, group A Streptococcus (GAS), causes acute rheumatic fever, the most common infectious cause of childhood heart disease in the world. In the United States, it has appeared in several localized outbreaks, and in 1999 the infection and its subsequent heart damage were responsible for 3,600 deaths. But GAS bacteria are relatively common and also cause a range of other diseases ranging from sore throats to toxic shock and flesh-eating disease. What makes different GAS strains invade different parts of the body, however, remains largely unknown. In addition, researchers have not known if different rheumatic fever outbreaks are caused by genetically similar bacteria or if different strains can emerge to cause the disease.

By isolating GAS bacteria from a person with the disease, scientists from the US National Institute of Allergy and Infectious Diseases (NIAID) have discovered several genes that are unique to those bacteria. Their discovery also reveals that two rheumatic fever outbreaks occurring 12 years apart in the area around Salt Lake City, Utah (USA), were caused by virtually identical GAS strains.

The study was directed by James Musser, Ph.D., chief of the laboratory of human bacterial pathogenesis at NIAID's Rocky Mountain Laboratories in Hamilton, MT (USA). Dr. Musser and colleagues determined the genetic blueprint of a GAS strain taken from a patient with rheumatic fever. All GAS bacteria that cause this disease are called M18 strains. The researchers then compared the M18 GAS blueprint to the DNA sequence of a non-M18 GAS strain, which does not cause the disease.

The researchers discovered several key differences between the two bacterial isolates. Although the M18 and non-M18 bacteria contained many of the same genes, the M18 strain had additional genes that appeared to encode novel bacterial toxins. In addition, most regions of variation between the two strains appeared to come from phages, viruses that can invade bacteria and insert large numbers of genes into the bacterium's own DNA. The presence of swappable toxin genes has important implications for understanding GAS outbreaks because it provides a mechanism for bacteria to exchange genes among themselves.

To see if individual GAS bacteria had different combinations of those genes, the researchers analyzed 36 strains isolated during different rheumatic fever outbreaks
from different parts of the country. Those strains showed little or no genetic variability. In particular, the study showed that GAS bacteria isolated from patients during a 1998-1999 Salt Lake City outbreak were nearly identical to those isolated from patients during the 1986-1987 epidemic in the same area. Therefore, the later outbreak appeared to be caused by a resurgence of the bacteria that caused the earlier cluster of illnesses, not by a new strain invading the area.

This research reveals some of the secrets of group A strep and is a major accomplishment in our quest to understand an important childhood disease,” said Anthony S. Fauci, M.D., NIAID director.




Related Links:
National Institute of Allergy and Infectious Diseases (NIAID)

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.